Positioning Providers to Take on Risk
As the market moves rapidly toward value-based care, one physician describes how working with New Century Health gave his practice the confidence and support to succeed in an advanced alternative payment model.
Other content in this Stream
Recent journal article details how NCH and Cancer Care Specialists of Illinois teamed up to slow growth in drug spend.
New Century Health Achieves NCQA Accreditation in Utilization Management
NCH also recertified by HITRUST® for patient privacy and data security protection.
Driving Culture Change in the Pursuit of Value: A Q&A with Cancer Care Specialists of Illinois
Dr. Mark Walshauser describes the impact of high-value oncology pathways and peer collaboration on his community practice.
Increasing use of real-world evidence is one of the most exciting trends in pathway development, our CMO tells Journal of Clinical Pathways.
Medscape delves into our work with a community oncology practice to implement high-value clinical pathways and engage providers
Dr. Jeffery Ward, an Oncologist / Hematologist with Swedish Cancer Institute, discusses the initial measures to protect patients, planning for the return of deferred care, and impact of COVID-19.
Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?
The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also need to be willing to make hard decisions around value, our CMO writes.
Cancer Care Specialists of Illinois reduced drug spend by 13.5% compared to peer practices by deploying our care pathway and physician collaboration protocols
On-Demand Webinar: Oncology in the Wake of COVID-19: The Lasting Impact on Cancer Care
Watch this on-demand webinar to explore the future of cancer care in a post COVID-19 world.
Our chief medical officer, Dr. Andrew Hertler, speaks with Journal of Clinical Pathways about our approach to high-value cancer care.
Caring for a population that is highly vulnerable to COVID-19, oncology practices have had to rapidly adapt for the pandemic. Listen to key takeaways from how oncology practices are responding.
Our CMO Dr. Andrew Hertler offers insights for minimizing patients' risk of COVID-19 when their cancer therapies cannot be delayed.
A compilation of infection prevention resources, regulatory updates and guidance for managing high-risk populations in this pandemic.
Creating a "Culture of Yes" in Prior Authorization
Prior authorization is a major source of frustration for providers and patients. Our CMO Dr. Andrew Hertler explains how a value-based approach can change that.
The Financial Burden of Breast Cancer
As more cancers are treated like chronic conditions, financial toxicity has become a greater problem, our CMO Dr. Andrew Hertler tells Next Avenue.
Navigating the CMS Oncology Care Model can be complicated. Listen to oncologist Dr. Wade describe his OCM experiences and how a partnership with New Century Health positioned his practice for success.
Lower Patient Costs Doesn’t Have to Mean Lower Profits
As the pace of treatment innovation threatens the financial health of both patients and oncology practices, it’s time to redefine reimbursement models to care for both financial and physical outcomes.
New Century Health’s clinical pathways are rigorously developed and maintained by company clinicians under the oversight of an independent Scientific Advisory Board. Take a glimpse inside the board.
Four Ways to Adapt to New Oncology Value-Based Models
Our CMO Dr. Andrew Hertler is quoted extensively in this Managed Healthcare Executive roundup of strategies for driving value in cancer care.
Oncology drug spending in the U.S. is on an unsustainable trajectory. Explore four paths to curb costs without compromising care.